Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2750
-0.0070 (-2.48%)
At close: Sep 2, 2025, 4:00 PM
0.2825
+0.0075 (2.73%)
After-hours: Sep 2, 2025, 7:05 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.43 million as of September 2, 2025. Its market cap has decreased by -77.26% in one year.
Market Cap
13.43M
Enterprise Value
11.54M
1-Year Change
-77.26%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.43M, a decrease of -79.65%. That is a compound annual growth rate of -52.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 13.78M | -48.18% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |